This inventor holds 38 USPTO granted patents and 1 published patent application, plus 12 CIPO patents and 5 EPO patents, primarily in Taxane Derivatives. Top assignees: Indena S.p.a., Inverni Della Beffa Spa, Societe De Recherches Industrielles Sori. Active years: 1978-2015.
Company Filing History:
27 out of 216 
8 out of 21 
3 out of 13 
Years Active: 1978-2015
Areas of Expertise:
Title: Bruno Gabetta: Innovator in Pharmacological Patents
Introduction
Bruno Gabetta, based in Milan, Italy, is a distinguished inventor recognized for his substantial contributions to the field of pharmacology. With a remarkable portfolio of 38 patents, Gabetta has been instrumental in developing innovative solutions in drug formulation and purification processes.
Latest Patents
His recent patents showcase groundbreaking advancements. One of his notable inventions is the "Process for the purification of 10-deacetylbaccatine III from 10-deacetyl-2-debenzoyl-2-pentenoylbaccatine III," which outlines a method for achieving high purities exceeding 99% using HPLC techniques. Furthermore, Gabetta has introduced a process for preparing "10-deacetyl-7,10-bis-trichloroacetylbaccatine III". This involves intricate purification followed by alkaline hydrolysis to remove protecting groups at specific positions.
In addition to these purification methods, Gabetta has also focused on solid forms of "Ortataxel" and has disclosed various forms and processes for preparing them. His findings include the preparation of Amorphous Form A and Crystalline Form B, detailing specific techniques for transitioning between these forms.
Career Highlights
Bruno Gabetta has had a significant impact through his work with prominent companies in the pharmaceutical industry, including Indena S.p.a. and Inverni Della Beffa Spa. His career is marked by ongoing innovation and a commitment to advancing pharmaceutical technology.
Collaborations
Collaborating with experts in the field, Gabetta has worked alongside esteemed colleagues such as Ezio Bombardelli and Maria J. Magistretti. Their joint efforts have furthered research and development prospects within the pharmaceutical sector, emphasizing the importance of teamwork in scientific advancements.
Conclusion
Bruno Gabetta's work exemplifies the spirit of innovation necessary for progress in pharmacology. With a rich portfolio of patents and a career dedicated to enhancing drug development processes, Gabetta continues to make significant strides in the pharmaceutical industry. His commitment to research and collaboration positions him as a leading figure in the realms of invention and innovation.